United Securities sets rating, TP for Jamjoom Pharma
Argaam19/05/2024
Jamjoom Pharma boosts presence in key markets, ramp up production: CEO
Argaam Special13/05/2024
Argaam19/05/2024
Argaam Special13/05/2024
| Last Trade | 137.20 |
| Change | 0.40 |
| Change (%) | 0.29 |
| Open | 136.80 |
| Low | 134.80 |
| High | 138.00 |
| Prev. Close | 136.80 |
| Change (3M) | (10.09 %) |
| Change (6M) | 27.04 % |
| Volume | 130,358 |
| Turnover | 17,831,097.00 |
| Transactions | 1,139 |
| Market Value | 9,604.00 |
| Avg. Volume (3M) | 373,609.22 |
| Avg. Turnover (3M) | 52,109,521.22 |
| Avg. Transaction (3M) | 3,041.66 |
| Change(12M) | n/a |
| YTD | 19.30 % |
|
Event Date
|
Event
|
Venue
|
|
|---|---|---|---|
|
04-06-2024
|
General Assembly | - | |
|
04-06-2024
|
Ex-dividend Date | - | |
|
25-03-2024
|
Conferences | - | |
|
25-03-2024
|
Financial results date | - | |
|
12-03-2024
|
General Assembly | - | |
| more | |||
Argaam22/11/2023
Argaam19/05/2024
Argaam14/04/2024
| Date | Research firm | Rating |
|
|
United Securities Company | Buy |
|
|
United Securities Company | Hold |
|
|
GIB Capital | Neutral |
|
|
Al Rajhi Capital | Overweight |
